Sir John Bell

We need to get the regulators on board.

We've got to get them to understand that we need diagnostics that define risk, not disease, because that's going to be a key bit of what we're going to try and do.

And we need to...

We need to understand that for a lot of these diseases, you have to intervene quite early to flatten that morbidity curve.

intersect with ai they do and we've got we've got two underpinning platforms well actually three underpinning platforms that go across all those domains larry was really keen that we became a real leader in ai so he's funded that with a massive compute capacity and remember most universities these days have a hard time competing on compute because it's exciting yeah yeah

So that is a real advantage to us.

He's also funded a great team.

We've recruited some people from Demis's shop who are obviously outstanding, but also others from around Europe.

So we've recruited now about 15 really outstanding machine learning and AI people.

And of course, we're now thinking about the other asset that the UK's got, and particularly in the healthcare space, is data.

So we do have some really unique data sets because those are the three bits of this that you need if you're going to make this work.

So we're pretty excited about that.

as an underpinning bit of the whole Ellison Institute strategy is to fundamentally underpin it with very strong AI.

Then the second platform is generative biology or synthetic biology, because this is a field which is sort of, as they say, limped along, but it's lacked a real focus.

But we've been able to recruit Jason Chin from the LMB in Cambridge, and he is one of the real

dramatic innovators in that space.

And we see there's a real opportunity now to synthesize large bits of DNA, introduce them into cells, microbes, use it for a whole variety of different purposes, try and transform plants at a level that people haven't done before.

So with AI and synthetic biology, we think we can feed all the main domains above us.

And

That's another exciting concept of what we're trying to do.